Genotype frequencies of CYP2C19, P2Y12 and GPIIIa polymorphisms in coronary heart disease patients of Han ethnicity, and their impact on clopidogrel …

W Ou, Y He, A Li, B Liu, L Jin - International heart journal, 2016 - jstage.jst.go.jp
To investigate the genotype frequencies of cytochrome P450, family2, subfamily C,
polypeptide19 (CYP2C19); P2Y12 receptor; and glycoprotein IIIa polymorphisms in patients …

P-glycoprotein polymorphism C3435T is associated with dose-adjusted clopidogrel and 2-oxo-clopidogrel concentration

D Stokanovic, VN Nikolic, SS Konstantinovic… - Pharmacology, 2016 - karger.com
Abstract Background/Aims: One of the most common polymorphisms of ABCB1 gene, a
synonymous mutation C3435T (rs1045642), is associated with increased in vivo activity. The …

Effects of Danshen capsules on the pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers

C Zhou, M Xu, H Yu, XT Zheng, ZF Zhong… - Food and Chemical …, 2018 - Elsevier
Nowadays, the Herb-drug combination is becoming increasingly popular in China. However,
the possible interaction induced by their combination was examined rarely. The aim of this …

Distribution of CYP2C19, ABCB1 and PON1 polymorphisms in Chinese Han, Hui, Uygur and Kazak patients with coronary atherosclerotic heart disease

L Ma, Y Yuan, J Li, C Yu, J Zhao - International Journal of …, 2020 - Wiley Online Library
Summary CYP2C19, ABCB1 and PON1 polymorphisms involve in the metabolism and
absorption of clopidogrel, which may be associated with interethnic variability of clopidogrel …

CRISPLD1 rs12115090 polymorphisms alters antiplatelet potency of clopidogrel in coronary artery disease patients in Chinese Han

JY Wang, YJ Zhang, H Li, XL Hu, MP Li, PY Song… - Gene, 2018 - Elsevier
Background Dual antiplatelet therapy (DAPT) with aspirin and clopidogrel is a
recommended treatment for coronary artery disease (CAD) patients undergoing …

Association of KDR rs1870377 genotype with clopidogrel resistance in patients with post percutaneous coronary intervention

W Al Awaida, AA Ahmed, AA Hamza, KI Amber… - Heliyon, 2021 - cell.com
Background Clopidogrel is an antiplatelet therapy that is widely used in pre and post
percutaneous (PCI) coronary intervention procedures to prevent platelet aggregation and …

Expression of ATP-binding cassette subfamily B member 1 gene in peripheral blood of patients with acute myocardial infarction

J Ruan, H Meng, Y Chen, Z Yan, X Li, F Meng - Bioengineered, 2022 - Taylor & Francis
This study aimed to determine the amount of expression of the ATP-binding cassette
subfamily B member 1 (ABCB1) gene chip as a prospective diagnostic marker for acute …

Pharmacogenetic testing by polymorphic markers 681G>A and 636G>A CYP2C19 gene in patients with acute coronary syndrome and gastric ulcer in the Republic of …

DS Fedorinov, KB Mirzaev, DV Ivashchenko… - Drug Metabolism and …, 2018 - degruyter.com
Background: The focus of the study is to determine the prevalence of CYP2C19 alleles,
associated with the risk of changes in the pharmacological response to clopidogrel and …

Effects of CYP2C19 genetic polymorphisms on the pharmacokinetic and pharmacodynamic properties of clopidogrel and its active metabolite in healthy Chinese …

BL Song, M Wan, D Tang, C Sun, YB Zhu, N Linda… - Clinical Therapeutics, 2018 - Elsevier
Purpose Some studies in the white population have shown that carriers of at least 1 loss-of-
function allele in the gene that encodes the cytochrome P-450 2C19 isozyme (CYP2C19) …

Фармакогенетика антитромботических препаратов: современное состояние проблемы

ЕС Кропачева - Атеротромбоз, 2018 - cyberleninka.ru
В обзоре отражены основные исследования, посвященные изучению генетических
мишеней индивидуальной вариабельности лекарственного ответа на …